Stanley T. Crooke

2013

In 2013, Stanley T. Crooke earned a total compensation of $2.8M as Chairman, President, Chief Executive Officer at Ionis Pharmaceuticals, a 77% increase compared to previous year.

Compensation breakdown

Bonus$803,907
Option Awards$877,737
Salary$735,169
Stock Awards$325,971
Other$15,752
Total$2,758,536

Crooke received $877.7K in option awards, accounting for 32% of the total pay in 2013.

Crooke also received $803.9K in bonus, $735.2K in salary, $326K in stock awards and $15.8K in other compensation.

Rankings

In 2013, Stanley T. Crooke's compensation ranked 2,789th out of 12,286 executives tracked by ExecPay. In other words, Crooke earned more than 77.3% of executives.

ClassificationRankingPercentile
All
2,789
out of 12,286
77th
Division
Manufacturing
927
out of 4,614
80th
Major group
Chemicals And Allied Products
243
out of 1,466
83rd
Industry group
Drugs
162
out of 1,160
86th
Industry
Pharmaceutical Preparations
135
out of 890
85th
Source: SEC filing on April 15, 2016.

Crooke's colleagues

We found three more compensation records of executives who worked with Stanley T. Crooke at Ionis Pharmaceuticals in 2013.

2013

B Parshall

Ionis Pharmaceuticals

Chief Operating Officer

2013

Brett Monia

Ionis Pharmaceuticals

Senior Vice President,

2013

Elizabeth Hougen

Ionis Pharmaceuticals

Chief Financial Officer

News

You may also like